GALT vs HSY · $142.4M cap vs P/E 36, rev $5.89B
Galectin Therapeutics Inc (GALT) versus Hershey Co (HSY) — a side-by-side from cached financials, not a winner call.
Galectin Therapeutics Inc (GALT) is a biotechnology company listed on US.
Hershey Co (HSY) is a confectioners company listed on US.
GALT does not have a complete income-statement cache yet.
Latest reported HSY revenue for 2026-06-28 was $5.89B. Net income was $892.8M. Revenue was up 89.8% from 2026-03-29 to 2026-06-28. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
GALT currently screens at market cap $142.4M. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
Not investment advice. Open the GALT and HSY stock pages for the full models.
Not investment advice.